Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NTN vs Limaprost vs combination for lumbar spinal canal stenosis with low back pain
jRCTs031200282Completed
- Sponsor
- Nippon Zoki Pharmaceutical
- Start
- Apr 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in lumbar spinal stenosis (LSS) comparing Neurotropin, Limaprost and Neurotropin + Limaprost (3 arms). Started Apr 2021; status: completed.
02
Drugs
vaccinia virus-inoculated rabbit skin extractlimaprost
03
Conditions
lumbar spinal stenosis (LSS)
Beyond the preview
Go deeper on jRCTs031200282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200282.